NeurologyLive® Staff

home / authors / neurologylive-staff

Articles

2020 Dravet Syndrome Foundation Conference Registration Open

2020 Dravet Syndrome Foundation Conference Registration Open

NeurologyLive® Staff
February 4th 2020

Dravet Syndrome Foundation has announced that registration for this year's DSF Conference is now open.

Phase 3b Trial of Aducanumab, Autoinjector FDA Approved for Fremanezumab, Ticagrelor Phase 3 Trial Announced

Phase 3b Trial of Aducanumab, Autoinjector FDA Approved for Fremanezumab, Ticagrelor Phase 3 Trial Announced

NeurologyLive® Staff
February 1st 2020

Neurology News Network for the week ending February 1, 2020.

NeurologyLive Friday 5 — January 31, 2020

NeurologyLive Friday 5 — January 31, 2020

NeurologyLive® Staff
February 1st 2020

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending January 31, 2020.

NDA Submission for Cataplexy Treatment, Siponimod Approved by EU for Progressive Multiple Sclerosis, RimabotulinumtoxinB Approved for Sialorrhea in Adults

NDA Submission for Cataplexy Treatment, Siponimod Approved by EU for Progressive Multiple Sclerosis, RimabotulinumtoxinB Approved for Sialorrhea in Adults

NeurologyLive® Staff
January 25th 2020

Neurology News Network for the week ending January 27, 2020.

NeurologyLive Friday 5 — January 24, 2020

NeurologyLive Friday 5 — January 24, 2020

NeurologyLive® Staff
January 25th 2020

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending January 24, 2020.

FDA Approves Intranasal Diazepam, Rimegepant and Erenumab Effectively Treats Refractory Migraine, MS Treatments Double Since 2011

FDA Approves Intranasal Diazepam, Rimegepant and Erenumab Effectively Treats Refractory Migraine, MS Treatments Double Since 2011

NeurologyLive® Staff
January 18th 2020

Neurology News Network for the week ending January 18, 2020.

NeurologyLive Friday 5 — January 17, 2020

NeurologyLive Friday 5 — January 17, 2020

NeurologyLive® Staff
January 18th 2020

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending January 17, 2020.

New Neuroimaging Guidelines for Migraine, Lemborexant Improves Sleep Onset, Patients with Parkinsons Have Compromised Swimming Ability

New Neuroimaging Guidelines for Migraine, Lemborexant Improves Sleep Onset, Patients with Parkinsons Have Compromised Swimming Ability

NeurologyLive® Staff
January 11th 2020

Neurology News Network for the week ending January 11, 2020.

Huntington Disease Trial Results; Mind Moments Podcast Now Live; PMM Trial Falls Short

Huntington Disease Trial Results; Mind Moments Podcast Now Live; PMM Trial Falls Short

NeurologyLive® Staff
January 4th 2020

Neurology News Network for the week ending January 4, 2020.

Amylyx Announces ALS Investigational Agent, FDA Approves Golodirsen for DMD, Wave Life Sciences Discontinues Suvodirsen, Discontinuation of Gosuranemab

Amylyx Announces ALS Investigational Agent, FDA Approves Golodirsen for DMD, Wave Life Sciences Discontinues Suvodirsen, Discontinuation of Gosuranemab

NeurologyLive® Staff
December 21st 2019

Neurology News Network for the week ending December 21, 2019.

CBD Reduces Seizures in Tuberous Sclerosis Complex, Fenfluramine Reduces Seizure Frequency While Improving Executive Function, Intranasal Diazepam Effective to Treat Seizures Regardless of Usage Frequency

CBD Reduces Seizures in Tuberous Sclerosis Complex, Fenfluramine Reduces Seizure Frequency While Improving Executive Function, Intranasal Diazepam Effective to Treat Seizures Regardless of Usage Frequency

NeurologyLive® Staff
December 14th 2019

Neurology News Network for the week ending December 14, 2019.

FDA Grants Breakthrough Designation for RightEye Vision System, Results from ESETT Trial Released, Conference Coverage of the 73rd Annual Meeting of the American Epilepsy Society

FDA Grants Breakthrough Designation for RightEye Vision System, Results from ESETT Trial Released, Conference Coverage of the 73rd Annual Meeting of the American Epilepsy Society

NeurologyLive® Staff
December 7th 2019

Neurology News Network for the week ending December 7, 2019.

Site Logo

Dravet Syndrome Foundation Hosts Research Roundtable at AES 2019

NeurologyLive® Staff
December 4th 2019

The 10th annual DSF Research Roundtable will take place on Thursday, December 5, in Baltimore, Maryland.

FDA Granted Approval to Cenobamate, Risdiplam is Granted Priority Review Designation, Riluzole Oral Film FDA Approved for Treatment of ALS

FDA Granted Approval to Cenobamate, Risdiplam is Granted Priority Review Designation, Riluzole Oral Film FDA Approved for Treatment of ALS

NeurologyLive® Staff
November 30th 2019

Neurology News Network for the week ending November 30, 2019.

Ubrogepant Provides Pain Relief for Acute Migraine, Cenobamate Reduces Focal-onset Seizures, Valbenazine Decreases Involuntary Movements in Patients with Tardive Dyskinesia

Ubrogepant Provides Pain Relief for Acute Migraine, Cenobamate Reduces Focal-onset Seizures, Valbenazine Decreases Involuntary Movements in Patients with Tardive Dyskinesia

NeurologyLive® Staff
November 23rd 2019

Neurology News Network for the week ending November 23, 2019.

Risdiplam Shows Positive Results in SMA, Study Trials for DMD Discontinued, Neflamapimod Granted Fast Track for Treatment of Dementia with Lewy Bodies

Risdiplam Shows Positive Results in SMA, Study Trials for DMD Discontinued, Neflamapimod Granted Fast Track for Treatment of Dementia with Lewy Bodies

NeurologyLive® Staff
November 16th 2019

Neurology News Network for the week ending November 16, 2019.

Acute Ischemic Stroke Guidelines Updated, Stephen Hahn Nominated for FDA, Satralizumab Reduces Risk of Relapse in NMOSD

Acute Ischemic Stroke Guidelines Updated, Stephen Hahn Nominated for FDA, Satralizumab Reduces Risk of Relapse in NMOSD

NeurologyLive® Staff
November 9th 2019

Neurology News Network for the week ending November 9, 2019.

Diroximel Fumarate Approved for MS; Personalized Interventions Improve Cognition; Zolgensma Trial Placed on Partial Hold

Diroximel Fumarate Approved for MS; Personalized Interventions Improve Cognition; Zolgensma Trial Placed on Partial Hold

NeurologyLive® Staff
November 2nd 2019

Neurology News Network for the week ending October 28, 2019.

Aducanumab Reversal Sends Drug to FDA, Cala Trio Reduces Hand Tremor, Ganaxolone Promising in Refractory Status Epilepticus

Aducanumab Reversal Sends Drug to FDA, Cala Trio Reduces Hand Tremor, Ganaxolone Promising in Refractory Status Epilepticus

NeurologyLive® Staff
October 26th 2019

Neurology News Network for the week ending October 26, 2019.

Lasmiditan Approved for Acute Migraine, Istradefylline Now Available for Parkinson Off Episodes, Omaveloxolone Promising in Friedreich's Ataxia

Lasmiditan Approved for Acute Migraine, Istradefylline Now Available for Parkinson Off Episodes, Omaveloxolone Promising in Friedreich's Ataxia

NeurologyLive® Staff
October 19th 2019

Neurology News Network for the week ending October 19, 2019.

Edasalonexent Promising for DMD, nVNS May Resolve Vestibular Migraine Symptoms, NIA Backs New Alzheimer Disease Research Centers

Edasalonexent Promising for DMD, nVNS May Resolve Vestibular Migraine Symptoms, NIA Backs New Alzheimer Disease Research Centers

NeurologyLive® Staff
October 12th 2019

Neurology News Network for the week ending October 12, 2019.

RimabotulinumtoxinB for Sialorrhea, Zogenix Resubmits Fenfluramine NDA, Long-Term Lemborexant Insomnia Data

RimabotulinumtoxinB for Sialorrhea, Zogenix Resubmits Fenfluramine NDA, Long-Term Lemborexant Insomnia Data

NeurologyLive® Staff
October 5th 2019

Neurology News Network for the week ending October 5, 2019.

Are Multiple Sclerosis Treatment Prices Interfering With Patient Care?

Are Multiple Sclerosis Treatment Prices Interfering With Patient Care?

NeurologyLive® Staff
October 4th 2019

Unsustainable costs pose challenges for patients and providers alike as the price of living with MS continues to rise.

EMA Removes Pregnancy Contraindications From MS Drugs, Oral Tavapadon Effective in Early-Stage Parkinson Disease, Pimavanserin Reduces Depression in PD

EMA Removes Pregnancy Contraindications From MS Drugs, Oral Tavapadon Effective in Early-Stage Parkinson Disease, Pimavanserin Reduces Depression in PD

NeurologyLive® Staff
September 28th 2019

Neurology News Network for the week ending September 28, 2019.

STOP 301 Trial of INP104 Initiated, Suvodirsen Gets Fast Track Designation, Siponimod EXPAND Data

STOP 301 Trial of INP104 Initiated, Suvodirsen Gets Fast Track Designation, Siponimod EXPAND Data

NeurologyLive® Staff
September 21st 2019

Neurology News Network for the week ending September 21, 2019.

Site Logo

NeurologyLive Adds Montefiore Health System to Its Strategic Alliance Partnership Program

NeurologyLive® Staff
September 16th 2019

Montefiore Health System will also be working with The American Journal for Managed Care.

Acadia Halts Phase 3 Pimavanserin Trial, Ofatumumab Superior In MS, Satralizumab Shines in NMOSD at ECTRIMS 2019

Acadia Halts Phase 3 Pimavanserin Trial, Ofatumumab Superior In MS, Satralizumab Shines in NMOSD at ECTRIMS 2019

NeurologyLive® Staff
September 14th 2019

Neurology News Network for the week ending September 14, 2019.

MS Immunization Guidelines, Prognostic Value of NfL in ALS, the Future of Focused Ultrasound

MS Immunization Guidelines, Prognostic Value of NfL in ALS, the Future of Focused Ultrasound

NeurologyLive® Staff
September 7th 2019

Neurology News Network for the week ending September 7, 2019.

Istradefylline OK'd for Parkinson, RimabotulinumtoxinB Approved for Chronic Sialorrhea, Dementia in Chronic Truamatic Encephalopathy

Istradefylline OK'd for Parkinson, RimabotulinumtoxinB Approved for Chronic Sialorrhea, Dementia in Chronic Truamatic Encephalopathy

NeurologyLive® Staff
August 31st 2019

Neurology News Network for the week ending August 31, 2019.

FDA Rejects Duchenne Muscular Dystrophy Drug Golodirsen, Pfizer Recalls Acute Migraine Treatment Relpax, Alzheimer Disease Update

FDA Rejects Duchenne Muscular Dystrophy Drug Golodirsen, Pfizer Recalls Acute Migraine Treatment Relpax, Alzheimer Disease Update

NeurologyLive® Staff
August 24th 2019

Neurology News Network for the week ending August 24, 2019.

<1
...
31323334353637>

Latest Updated Articles

Jannis Müller, MD, MSc (Credit: LinkedIn)
Published: May 14th 2025 | Updated: May 16th 2025
Observed Differences in PIRA Definition Call for More Standardized Agreement on Term
Giulia Fadda, MD (Credit: Ottawa Hospital Research Institute)
Published: May 12th 2025 | Updated: May 13th 2025
Serum Neurofilament Light Chain Limited in Predicting MOGAD Attacks but Correlates With Attack Severity
FDA Approves Diazoxide Choline Extended-Release Tablets for Hyperphagia in Prader-Willi Syndrome
Published: March 27th 2025 | Updated: March 28th 2025
FDA Approves Diazoxide Choline Extended-Release Tablets for Hyperphagia in Prader-Willi Syndrome
BTK Inhibitor Tolebrutinib Shows Greater Effectiveness in Multiple Sclerosis with Higher Paramagnetic Rim Lesion Counts
Published: March 4th 2025 | Updated: March 19th 2025
BTK Inhibitor Tolebrutinib Shows Greater Effectiveness in Multiple Sclerosis with Higher Paramagnetic Rim Lesion Counts
FDA Approves Vertex Pharmaceuticals' Suzetrigine for Acute Pain Management
Published: January 30th 2025 | Updated: February 21st 2025
FDA Approves Vertex Pharmaceuticals' Suzetrigine for Acute Pain Management
Cerebrospinal Fluid Lipids Shows Promise as Biomarkers for Differentiating NMOSD and MS
Published: February 15th 2025 | Updated: February 18th 2025
Cerebrospinal Fluid Lipids Shows Promise as Biomarkers for Differentiating NMOSD and MS
© 2025 MJH Life Sciences

All rights reserved.